KR950032184A - 3-(2-아미노에틸)-4-[3-(트리플루오로메틸)벤조일]-3, 4-디히드로-2h-1, 4-벤즈옥사진 유도체, 그 제조방법 및 그 치료학적 적용 - Google Patents

3-(2-아미노에틸)-4-[3-(트리플루오로메틸)벤조일]-3, 4-디히드로-2h-1, 4-벤즈옥사진 유도체, 그 제조방법 및 그 치료학적 적용 Download PDF

Info

Publication number
KR950032184A
KR950032184A KR1019950001835A KR19950001835A KR950032184A KR 950032184 A KR950032184 A KR 950032184A KR 1019950001835 A KR1019950001835 A KR 1019950001835A KR 19950001835 A KR19950001835 A KR 19950001835A KR 950032184 A KR950032184 A KR 950032184A
Authority
KR
South Korea
Prior art keywords
group
dihydro
compound
general formula
inden
Prior art date
Application number
KR1019950001835A
Other languages
English (en)
Inventor
조르쥬 빠스칼
프로스트 죠나단
빠쏘 빠트릭
루쎌 꼬린느
바르트쉬 레진느
하워드 윌리엄스 폴
끌로드 뮐레 쟝
Original Assignee
에. 뚜레 레메뜨르
신떼라보 소시에떼 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9401196A external-priority patent/FR2715659B1/fr
Priority claimed from FR9401197A external-priority patent/FR2715655B1/fr
Application filed by 에. 뚜레 레메뜨르, 신떼라보 소시에떼 아노님 filed Critical 에. 뚜레 레메뜨르
Publication of KR950032184A publication Critical patent/KR950032184A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

본 발명은 일반식(Ⅰ)에 해당하는 화합물을 제공한다.
상기식에서 R1은 수소원자, 플루오르원자, 염소원자, 메틸기, C1-C3알콕시기 또는 니트로기를 나타내며, R3는 수소원자 또는 C1-C3알킬기를 나타내며, R4는 2, 3-이히드로-1H-인덴-2-일, 2, 3-디히드로-1H-일 또는 1, 2, 3, 4-테트라히들고 나프탈렌-1-일기를 나타내거나 양자택일로 R3및 R4는 질소원자와 함께 1, 2, 3, 4-테트라히드로-9H-피리도[3,4-b]인돌-2-일기, 1, 2, 3, 4-테트라히드로-9H-피리도[4, 3-b]인돌-3-일기, 4, 5, 6, 7-테트라히드로티에노[2, 3-c]피리드-6-일기, 4, 5, 6, 7-테트라히드로티에노[3, 2-c]피리드-6-일기 또는 2, 3-디히드로-1H-이소인돌-2-일기를 형성한다.

Description

3-(2-아미노에틸)-4-[3-(트리플루오로메틸)벤조일]-3,4-디히드로-2H-1,4-벤즈옥사진 유도체, 그 제조방법 및 그 치료학적 적용
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 염기의 형태 또는 산의 부가염 형태로 다음 일반식(I)에 해당하는 순수한 광학 이성질체 또는 광학 이성질체의 혼합물의 형태인 것을 특징으로 하는 화합물.
    상기식에서 R1은 수소원자, 플루오르원자, 염소원자, 메틸기, C1-C3알콕시기 또는 니트로기를 나타내며, R3는 단독으로 수소원자 또는 C1-C3알킬기를 나타내며, R4는 단독으로 2,3-디히드로-1H-인덴-2-일기, 2,3-디히드로-1H-인덴-1-일기 또는 1,2,3,4-테트라히드로 나프탈렌-1-일기를 나타내거나 또는 양자택일로, R3및 R4는 질소원자와 함께 1,2,3,4-테트라히드로-9H-피리도[3,4-b]인돌-2-일기, 1,2,3,4-테트라히드로-9H-피리도[4,3-b]인돌-3-일기, 4,5,6,7-테트라히드로티에노[2,3-c]피리드-6-일기, 4,5,6,7-테트라히드로티에노[3,2-c]피리드-6-일기 또는 2,3-디히드로-1H-이소인돌-2-일기를 함께 형성하며, 이들의 구조식은 각각 다음과 같다;
  2. 제1항에 있어서, R1은 플루오르원자, 염소원자, 메틸기 또는 메톡시기를 나타내며, R3는 수소원자 또는 C1-C3알킬기를 나타내며 R4는 2, 3-디히드로-1H-인덴-2-일기, 2, 3-디히드로-1H-인덴-1-일기 또는 1, 2, 3, 4-테트라히드로나프탈렌-1-일기를 나타내는 것을 특징으로 하는 화합물.
  3. R1의 특허청구의 번위 제1항에 정의된 바와 같은 일반식(Ⅱ)
    의 2-아미노페놀을 무수트리플루오로아세트산과 반응시켜서 일반식(Ⅳ)
    의 아미드를 얻고 이것을 에틸 4-브로모-2부텐오에이트와 반응시키고 이어서 그렇게 하여 얻어진 일반식(Ⅵ)
    의 에틸 3, 4-디히드로-2H-1, 4-벤즈옥사진-3-아세테이트 유도체의 에스테르 작용기를 환원제로 환원시켜서 일반식(Ⅶ)
    의 3, 4-디히드로-2H-1, 4-벤즈옥사진-3-에탄올 유도체를 얻고 이것을 3-(트리플루오로메틸)벤조일클로라이드와 반응시켜서 일반식(Ⅸ)
    의 알코올을 얻고 이것을 염화티오닐과 반응시켜서 일반식(Ⅹ)
    의 화합물을 얻고 최종적으로 이 화합물을 R3및 R4가 특허청의 범위 제1항에 규정된 바의 일반식 HNR3R4의 아민과 반응시키는 것을 특징으로 하는 특허청구의 범위 제1항에 따른 화합물의 제조방법.
  4. 특허청구의 범위 제1항에 따른 화합물로 구성되는 것을 특징으로 하는 약제.
  5. 특허청구의 범위 제1항에 따른 화합물을 부형제와 결합하여 함유하는 것을 특징으로 하는 약학적 조성물.
    ※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
KR1019950001835A 1994-02-03 1995-02-02 3-(2-아미노에틸)-4-[3-(트리플루오로메틸)벤조일]-3, 4-디히드로-2h-1, 4-벤즈옥사진 유도체, 그 제조방법 및 그 치료학적 적용 KR950032184A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9401196A FR2715659B1 (fr) 1994-02-03 1994-02-03 Dérivés de 3-(2-aminoéthyl)-4-[3-(trifluorométhyl)benzoyl]-3,4-dihydro-2H-1,4-benzoxazine, leur préparation et leur application en thérapeutique.
FR94.01196 1994-02-03
FR94.01197 1994-02-03
FR9401197A FR2715655B1 (fr) 1994-02-03 1994-02-03 Dérivés de 3-(2-aminoéthyl)-4-benzoyl-3,4-dihydro-2H-1,4-benzoxazine, leur préparation et leur application en thérapeutique.

Publications (1)

Publication Number Publication Date
KR950032184A true KR950032184A (ko) 1995-12-20

Family

ID=26230930

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950001835A KR950032184A (ko) 1994-02-03 1995-02-02 3-(2-아미노에틸)-4-[3-(트리플루오로메틸)벤조일]-3, 4-디히드로-2h-1, 4-벤즈옥사진 유도체, 그 제조방법 및 그 치료학적 적용

Country Status (19)

Country Link
US (1) US5550125A (ko)
EP (1) EP0666260B1 (ko)
JP (1) JPH07278123A (ko)
KR (1) KR950032184A (ko)
CN (1) CN1109880A (ko)
AT (1) ATE182887T1 (ko)
AU (1) AU687134B2 (ko)
CA (1) CA2141728A1 (ko)
CZ (1) CZ27095A3 (ko)
DE (1) DE69511127D1 (ko)
FI (1) FI950457A (ko)
HU (1) HUT71238A (ko)
IL (1) IL112528A (ko)
NO (1) NO304229B1 (ko)
NZ (1) NZ270444A (ko)
PL (1) PL307040A1 (ko)
RU (1) RU2136670C1 (ko)
SK (1) SK12895A3 (ko)
ZA (1) ZA95834B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2235368T3 (es) * 1997-10-27 2005-07-01 Sumitomo Pharmaceuticals Company, Limited Derivados de amida para tratar alteraciones neurodegenerativas de la retina.
JP3201998B2 (ja) * 1998-12-16 2001-08-27 サムソン ジェネラル ケミカルズ カンパニー リミテッド （ｓ）−ベンゾオキサジン誘導体の製造方法及び（ｒ）−ベンゾオキサジン誘導体のラセミ化方法
KR100397491B1 (ko) * 2000-12-05 2003-09-13 이수화학 주식회사 광학활성 (ｓ)-벤즈옥사진 유도체 및 그의 제조방법
EP1856126A2 (en) * 2005-02-17 2007-11-21 Wyeth a Corporation of the State of Delaware Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
CN101268075A (zh) * 2005-07-28 2008-09-17 百时美施贵宝公司 作为5-羟色胺受体激动剂和拮抗剂的取代的四氢-1h吡啶并[4,3,b]吲哚
AP2013007153A0 (en) 2011-03-18 2013-09-30 Lupin Ltd Benzo [B] [1,4] oxazin derivatives as calcium sensing receptor modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1287584B (de) * 1962-07-04 1969-01-23 Thomae Gmbh Dr K Verfahren zur Herstellung von 2, 3-Dihydro-1, 4-benzoxazinderivaten
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
FR2619111B1 (fr) * 1987-08-07 1991-01-11 Synthelabo Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
FR2702477B1 (fr) * 1993-03-08 1995-04-28 Synthelabo Dérivés de benzoxazine, leur préparation et leur application en thérapeutique.

Also Published As

Publication number Publication date
CZ27095A3 (en) 1995-09-13
ATE182887T1 (de) 1999-08-15
NO304229B1 (no) 1998-11-16
RU2136670C1 (ru) 1999-09-10
CN1109880A (zh) 1995-10-11
NZ270444A (en) 1996-02-27
IL112528A (en) 1999-04-11
RU95101386A (ru) 1996-11-20
EP0666260B1 (fr) 1999-08-04
IL112528A0 (en) 1995-05-26
FI950457A (fi) 1995-08-04
JPH07278123A (ja) 1995-10-24
NO950378D0 (no) 1995-02-02
AU687134B2 (en) 1998-02-19
NO950378L (no) 1995-08-04
SK12895A3 (en) 1995-08-09
ZA95834B (en) 1996-02-12
HUT71238A (en) 1995-11-28
PL307040A1 (en) 1995-08-07
US5550125A (en) 1996-08-27
EP0666260A1 (fr) 1995-08-09
HU9500310D0 (en) 1995-03-28
CA2141728A1 (en) 1995-08-04
DE69511127D1 (de) 1999-09-09
AU1154595A (en) 1995-08-10
FI950457A0 (fi) 1995-02-02

Similar Documents

Publication Publication Date Title
KR880006247A (ko) 티에노피리디논 및 이의 제조방법
KR930017900A (ko) 벤즈이미다졸릴 유도체, 이 화합물을 함유하는 약제학적 조성물 및 이의 제조방법
KR950032087A (ko) N-(3-아미노프로필)-n-페닐-5,6,7,8-테트라히드로나프탈렌-2-카르복사미드 유도체, 이것의 제조방법 및 이것의 치료에의 이용
HUP0100287A2 (hu) Rákellenes hatású tienopirimidin- és tienopiridin-származékok
KR950014108A (ko) 복소환 화합물, 그의 제조방법 및 용도
KR950032184A (ko) 3-(2-아미노에틸)-4-[3-(트리플루오로메틸)벤조일]-3, 4-디히드로-2h-1, 4-벤즈옥사진 유도체, 그 제조방법 및 그 치료학적 적용
KR970001335A (ko) N-[(1, 4- 디아자비시클로[2.2.2]옥트-2-일)메틸]벤즈아미드 유도체, 이것의 제조방법 및 치료에의 이용
EP1669359B1 (en) A process for the preparation of olanzapine and an intermediate therefor
KR850006411A (ko) 이속사졸 유도체의 제조방법
KR920006346A (ko) 3-(1h-인다졸-3-일)-4-피리딘아민, 이의 제조방법, 이의 제조를 위한 중간체 및 약제로서의 이의 용도
EP1106608B1 (fr) Nouveaux dérivés (dihydro)benzoxaziniques et (dihydro)benzothiaziniques substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
ES2080891T3 (es) Preparacion de derivados de amina norbornil opticamente activos.
Lukevics et al. Synthesis and cytotoxicity of silyl-and carbonyl-substituted isoxazoles
KR940005619A (ko) 2-아미노-n-[[[4-(아미노카르보닐)피리미딘-2-일]아미노]알킬]피리미딘-4-카르복시아미드 유도체, 이것의 제법 및 치료에의 이용
IL56507A (en) (trihalomethyl)dimethyloxabicyclohexanone derivatives for the preparation of cis dihalovinyldimethylcyclopropanecarboxylic acids
HUT48201A (en) Herbicide comprising anilide derivatives and process for producing such compounds
HU209426B (en) Process for the preparation of insecticidal, acaricidal and nematocidal 2-aryl-1-substituted-5-(trifluoromethyl) pyrolle compounds
KR960700232A (ko) 신규시클로프로필유도체, 그 제조방법 및 용도(new cyclopropyl deri vatives, preparation method thereof and applications)
KR800000854B1 (ko) 나프티리딘 유도체의 제법
JP3496979B2 (ja) 置換インドール−３−酢酸化合物および置換ベンゾフラニル−３−酢酸化合物の製造方法
FR2530236A1 (fr) Nouveaux derives aminoalkyl naphtaleniques, leurs sels d'addition d'acide et le procede de preparation ainsi que l'application en therapeutique de ces derives et sels
CA2337248A1 (en) Process for the preparation of an indole derivative
KR950017998A (ko) 신규한 퀴놀론계 유도체 및 그의 제조 방법
KR20020015810A (ko) 폴리에톡실레이티드 피라졸로피리미디논 유도체, 그의제조방법 및 그를 포함하는 발기부전증 치료용 약제학적조성물
KR950018000A (ko) 신규한 퀴놀론계 유도체 및 그의 제조 방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid